# Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles

> **NCT00669786** · PHASE3 · COMPLETED · sponsor: **Instituto Valenciano de Infertilidad, IVI VALENCIA**

## Conditions studied

- Ovarian Stimulation

## Interventions

- **DRUG:** Human Menopausal Gonadotropin (HMG) & - Recombinant Follicle Stimulating Hormone (r-FSH)

## Key facts

- **NCT ID:** NCT00669786
- **Lead sponsor:** Instituto Valenciano de Infertilidad, IVI VALENCIA
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2008-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00669786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00669786, "Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00669786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*